JP2004269517A5 - - Google Patents

Download PDF

Info

Publication number
JP2004269517A5
JP2004269517A5 JP2004041914A JP2004041914A JP2004269517A5 JP 2004269517 A5 JP2004269517 A5 JP 2004269517A5 JP 2004041914 A JP2004041914 A JP 2004041914A JP 2004041914 A JP2004041914 A JP 2004041914A JP 2004269517 A5 JP2004269517 A5 JP 2004269517A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
acceptable salt
pseudoephedrine
pharmaceutical composition
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004041914A
Other languages
Japanese (ja)
Other versions
JP3987501B2 (en
JP2004269517A (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2004041914A priority Critical patent/JP3987501B2/en
Priority claimed from JP2004041914A external-priority patent/JP3987501B2/en
Publication of JP2004269517A publication Critical patent/JP2004269517A/en
Publication of JP2004269517A5 publication Critical patent/JP2004269517A5/ja
Application granted granted Critical
Publication of JP3987501B2 publication Critical patent/JP3987501B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Claims (6)

（Ａ）シュードエフェドリンまたはその薬学上許容される塩、（Ｂ）フェニレフリンまたはメトキシフェナミンもしくはこれらの薬学上許容される塩、および（Ｃ）ダツラエキス、ベラドンナ総アルカロイド、ベラドンナエキス、ロートエキスからなる群より選択される少なくとも１種を含有することを特徴とする医薬組成物。   (A) Pseudoephedrine or a pharmaceutically acceptable salt thereof, (B) phenylephrine or methoxyphenamine or a pharmaceutically acceptable salt thereof, and (C) datsura extract, belladonna total alkaloid, belladonna extract, funnel extract A pharmaceutical composition comprising at least one selected from the above. （Ａ）シュードエフェドリンまたはその薬学上許容される塩、（Ｂ）フェニレフリンまたはその薬学上許容される塩、および（Ｃ）ベラドンナ総アルカロイドを含有することを特徴とする、請求項１に記載の医薬組成物。The medicament according to claim 1, comprising (A) pseudoephedrine or a pharmaceutically acceptable salt thereof, (B) phenylephrine or a pharmaceutically acceptable salt thereof, and (C) a belladonna total alkaloid. Composition. Ａ）シュードエフェドリンまたはその薬学上許容される塩、（Ｂ）シュードエフェドリン１００重量部に対して１〜１１０重量部のフェニレフリンまたはその薬学上許容される塩、および（Ｃ）シュードエフェドリン１００重量部に対して０．０５〜５重量部のベラドンナ総アルカロイドを含有することを特徴とする、請求項２に記載の医薬組成物。A) pseudoephedrine or a pharmaceutically acceptable salt thereof, (B) 1 to 110 parts by weight of phenylephrine or a pharmaceutically acceptable salt thereof per 100 parts by weight of pseudoephedrine, and (C) 100 parts by weight of pseudoephedrine. The pharmaceutical composition according to claim 2, comprising 0.05 to 5 parts by weight of total belladonna alkaloids. 鼻炎用または感冒用である、請求項１〜３のいずれか一項に記載の医薬組成物。The pharmaceutical composition according to any one of claims 1 to 3, which is used for rhinitis or for the common cold. 鼻炎用である、請求項１〜３のいずれか一項に記載の医薬組成物。The pharmaceutical composition according to any one of claims 1 to 3, which is used for rhinitis. さらに、抗ヒスタミン薬、消炎酵素、抗炎症薬、キサンチン類から選択される少なくとも１種を含有する、請求項１〜５のいずれか一項に記載の医薬組成物。Furthermore, the pharmaceutical composition as described in any one of Claims 1-5 containing at least 1 sort (s) selected from an antihistamine, an anti-inflammatory enzyme, an anti-inflammatory drug, and xanthines.
JP2004041914A 2003-02-19 2004-02-18 Pharmaceutical composition Expired - Lifetime JP3987501B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2004041914A JP3987501B2 (en) 2003-02-19 2004-02-18 Pharmaceutical composition

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003040664 2003-02-19
JP2004041914A JP3987501B2 (en) 2003-02-19 2004-02-18 Pharmaceutical composition

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2006313255A Division JP2007039473A (en) 2003-02-19 2006-11-20 Medicinal composition

Publications (3)

Publication Number Publication Date
JP2004269517A JP2004269517A (en) 2004-09-30
JP2004269517A5 true JP2004269517A5 (en) 2007-01-25
JP3987501B2 JP3987501B2 (en) 2007-10-10

Family

ID=33134116

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004041914A Expired - Lifetime JP3987501B2 (en) 2003-02-19 2004-02-18 Pharmaceutical composition

Country Status (1)

Country Link
JP (1) JP3987501B2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9005652B2 (en) 2006-07-25 2015-04-14 Wyeth Chewable tablet containing phenylephrine
JP5896806B2 (en) * 2012-03-28 2016-03-30 ロート製薬株式会社 Oral composition
CN102641367B (en) * 2012-05-19 2014-02-26 陈亚徽 Marsdenia tenacissima throat-clearing and cough-relieving sugar and granules
JP6616968B2 (en) * 2014-06-25 2019-12-04 興和株式会社 Pharmaceutical composition
CN104623586A (en) * 2014-12-25 2015-05-20 陆莎 Traditional Chinese medicine mixture for treating cough

Similar Documents

Publication Publication Date Title
EP2346329B1 (en) A method of inhibiting hepatitis c virus by combination of a 5,6-dihydro-1h-pyridin-2-one and one or more additional antiviral compounds
JP2005524658A5 (en)
MY130803A (en) New quinuclidine amide derivatives
JP2007529532A5 (en)
TW200635897A (en) Piperidine derivatives and their use as anti-inflammatory agents
JP2009517411A5 (en)
CN106573006A (en) Heterocyclic amides as RIP1 kinase inhibitors as medicaments
JP2007522094A5 (en)
RS50924B (en) Oral dosage form for propiverine or its pharmaceutically acceptable salts with an extended release of the active ingredient
JP2005538121A5 (en) Multiple delayed release antiviral product, its use and formulation
JP2008523153A5 (en)
JP2012502037A5 (en)
NO20062061L (en) New substituted, 4-amino-thiazolo [4,5-D] pyrimines, useful as chemokine receptor antagonists, ESP. CX3CR1
WO2004000840A3 (en) Quinuclidine derivatives and pharmaceutical compositions containing the same
SE0104341D0 (en) New use
WO2005118579A3 (en) Thiazole derivatives as chemokine receptor antagonists
Rosini et al. The bivalent ligand approach as a tool for improving the in vitro anti‐Alzheimer multitarget profile of dimebon
WO2006138373A3 (en) MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF
JP2008110970A5 (en)
JP2007515426A5 (en)
JP2006515299A5 (en)
JP2005522432A5 (en)
HUP0401805A2 (en) Compounds suitable for treating pulmonary diseases
JP2004269517A5 (en)
JP2009512705A5 (en)